Neogenomics (NEO) Research & Development: 2011-2025
Historic Research & Development for Neogenomics (NEO) over the last 14 years, with Sep 2025 value amounting to $8.7 million.
- Neogenomics' Research & Development rose 13.14% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year increase of 18.31%. This contributed to the annual value of $31.2 million for FY2024, which is 14.10% up from last year.
- Per Neogenomics' latest filing, its Research & Development stood at $8.7 million for Q3 2025, which was down 3.65% from $9.0 million recorded in Q2 2025.
- Neogenomics' Research & Development's 5-year high stood at $10.2 million during Q1 2025, with a 5-year trough of $2.5 million in Q1 2021.
- Moreover, its 3-year median value for Research & Development was $7.7 million (2024), whereas its average is $7.9 million.
- Per our database at Business Quant, Neogenomics' Research & Development surged by 305.38% in 2021 and then dropped by 27.72% in 2023.
- Quarterly analysis of 5 years shows Neogenomics' Research & Development stood at $8.5 million in 2021, then dropped by 21.59% to $6.7 million in 2022, then grew by 6.77% to $7.1 million in 2023, then rose by 11.81% to $8.0 million in 2024, then increased by 13.14% to $8.7 million in 2025.
- Its Research & Development stands at $8.7 million for Q3 2025, versus $9.0 million for Q2 2025 and $10.2 million for Q1 2025.